Mayer Davidson to Treatment Outcome
This is a "connection" page, showing publications Mayer Davidson has written about Treatment Outcome.
Connection Strength
0.427
-
Sitagliptin compared with thiazolidinediones as a third-line oral antihyperglycemic agent in type 2 diabetes mellitus. Endocr Pract. 2011 Sep-Oct; 17(5):691-8.
Score: 0.080
-
Effect of a nurse-directed diabetes disease management program on urgent care/emergency room visits and hospitalizations in a minority population. Diabetes Care. 2007 Feb; 30(2):224-7.
Score: 0.059
-
Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients. Diabetes Care. 2006 Nov; 29(11):2504-5.
Score: 0.058
-
SF-36 and diabetes outcome measures. Diabetes Care. 2005 Jun; 28(6):1536-7.
Score: 0.052
-
Effect of Pancreas Tonic (an ayurvedic herbal supplement) in type 2 diabetes mellitus. Metabolism. 2004 Sep; 53(9):1166-73.
Score: 0.050
-
Triple therapy: definitions, application, and treating to target. Diabetes Care. 2004 Jul; 27(7):1834-5.
Score: 0.049
-
Effect of nurse-directed diabetes care in a minority population. Diabetes Care. 2003 Aug; 26(8):2281-7.
Score: 0.046
-
The influence of diabetes mellitus on the risk of abdominal aortic surgery. Am Surg. 1994 Jun; 60(6):436-40.
Score: 0.024
-
Controlling blood glucose levels in patients with type 2 diabetes mellitus. An evidence-based policy statement by the American Academy of Family Physicians and American Diabetes Association. J Fam Pract. 2000 May; 49(5):453-60.
Score: 0.009